HYDERABAD, India, Nov. 24, 2025 /PRNewswire/ — According to Mordor Intelligence, the cell therapy market is valued at USD 5.5 billion in 2025 and is projected to surpass USD 12.2 billion by 2030, advancing at an 17.05% CAGR, driven by rising commercialization of advanced therapies, increasing investment in manufacturing capacity, and significant progress in allogeneic, off-the-shelf treatment platforms. Growing demand for personalized and regenerative treatment options, combined with regulatory support for breakthrough therapies, continues to propel the market into a high-growth phase. As biopharmaceutical companies accelerate the development of scalable and next-generation cell therapy solutions, the sector is transitioning from early-stage innovation to broader clinical and commercial integration.
Regional Market Insights
North America continues to lead the global cell therapy market due to strong regulatory pathways, advanced manufacturing infrastructure, and high investment in R&D. The United States remains at the forefront of CAR-T development, allogeneic platform research, and commercialization of next-generation therapies.
Asia-Pacific is projected to grow at the fastest pace through 2030, supported by rising clinical trial activity, cost-efficient production capabilities, and increasing government initiatives to strengthen biotechnology innovation. Countries such as China, Japan, and South Korea are accelerating approvals and expanding research ecosystems for cell-based therapies.
Emerging Key Trends
Rapid Commercialization of Autologous Therapies
Autologous therapies have gained strong clinical traction as personalized treatment solutions, especially in oncology. Their increasing regulatory approvals and expanding real-world evidence base are encouraging providers and payers to integrate these therapies into routine treatment pathways. Faster production workflows and optimized patient cell-collection methods are further improving accessibility.
Expansion Beyond Oncology into Regenerative & Immune Disorders
While oncology remains the leading application segment, cell therapy is expanding into autoimmune, cardiovascular, neurological, and musculoskeletal indications. This diversification is broadening the treatment landscape and creating new opportunities for research organizations and developers targeting unmet medical needs.
Comprehensive Market Segmentation Overview
By Therapy Type
Autologous Cell Therapy
Allogeneic Cell Therapy
By Cell Type
Stem Cell Therapy
Hematopoietic Stem Cells
Mesenchymal Stem Cells
Induced Pluripotent Stem Cells
Immune Cell Therapy
T Cell Therapy
NK Cell Therapy
Dendritic Cell Therapy
Fibroblast & Chondrocyte-based Therapies
By Application
Oncology
Cardiovascular Diseases
Orthopedic & Musculoskeletal
Neurological Disorders
Autoimmune Disorders
Wound Healing & Dermatology
Ophthalmology
By End User
Hospitals & Clinics
Specialty Cell- & Gene-Therapy Centers
Academic & Research Institutes
Contract Manufacturing & CRO Facilities
By Geography
North America
Europe
Asia-Pacific
Middle East & Africa
South America
For a full breakdown of market size, segmentation data, and competitive intelligence, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/cell-therapy-market?utm_source=prnewswire
Competitive Environment
The cell therapy market is moderately consolidated, with global biotechnology leaders and emerging specialists contributing to a highly competitive and innovation-driven ecosystem. Companies are prioritizing advancements in gene-modified cells, off-the-shelf therapeutic platforms, and automated production technologies. Strategic collaborations, licensing agreements, and investment in AI-enabled manufacturing are becoming key approaches to expand development pipelines and accelerate commercialization.
Key Companies in the Cell Therapy Include:
Corestem Inc.
Chiesi Farmaceutici S.p.A.
Tego Science
Allogene Therapeutics Inc.
Takeda Pharmaceuticals
Check out related reports published by Mordor Intelligence:
CAR T-Cell Therapy Market: The CAR T-Cell Therapy Market is Segmented by Target Antigen (CD19, BCMA, CD22, GD2), Type (Abecma, Breyanzi), Cell Source (Autologous and Allogenic), Application (Leukemia, Lymphoma), End User (Hospitals, Cancer Care Treatment Centers), and Geography (North America, Europe, Asia-Pacific).
Novartis AG, Bristol-Myers Squibb Company, Johnson & Johnson, Sorrento Therapeutics, Inc. and Gilead Sciences, Inc. (Kite Pharma) are the major companies operating in this market.
Read more about companies active in CAR T-Cell Therapy: https://www.mordorintelligence.com/industry-reports/car-t-cell-therapy/companies?utm_source=prnewswire
Cell Culture Market: The Cell Culture Market Report is Segmented by Product (Equipment and Consumables), Cell Type (Mammalian Cells), Technology (2-D Cell Culture and 3-D Cell Culture), Application (Biopharmaceutical Production, Drug Discovery & Development), End-User (Pharmaceutical & Biotechnology Companies), and Geography (North America, Europe).
Thermo Fisher Scientific, Danaher Corporation, Sartorius AG, Merck KGaA and Becton, Dickson and Company are the major companies operating in this market.
Read more about companies active in Cell Culture: https://www.mordorintelligence.com/industry-reports/cell-culture-market/companies?utm_source=prnewswire
Gene Therapy Market: The Gene Therapy Market Report Segments the Industry Into by Vector Type (Adeno Virus Vector), Indication (Oncology, Rare Metabolic Disorders, and More), Delivery Mode (In Vivo Gene Delivery and Ex Vivo Gene Delivery), End User (Hospitals and Clinics), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, South America).
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries, please contact:
[email protected]
https://www.mordorintelligence.com/contact-us
Logo: https://mma.prnewswire.com/media/2746908/Mordor_Intelligence_Logo.jpg
SOURCE Mordor Intelligence Private Limited
